PATENT CLAIM ANALYSIS

Application Number: 15772919
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "394000"]

Abstract:
The present invention relates to a novel family of covalent kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the Tec kinase family, particularly ITK, BTK, BMX, Tec and/or RLK. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvate of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof and its use in therapy.

Claim (Index 31):
A pharmaceutical composition comprising the compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, solvates of a salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof in combination with at least one pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 93.0
- Lexical Diversity: 1.49123
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15262193', '14404497', '14412982', '15037923', '14009635']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940885005162478
- 35 USC 102 Novelty (BERT): 0.5304008737025623
- Combined Prediction Score: 0.7677197378348792
- Mean Citation Score: 352.284728
- Max Citation Score: 364.62503
- Similarity Product: 318.83904353469615

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test